🔎 Trials Near Me

Gara Jalqabaatti › Kansara Harkaa (Karsinomaa Seli Renal) › Ohio › Columbus

Qorannoo klinikaalii Kansara Harkaa (Karsinomaa Seli Renal) Columbus, OH keessatti

Qorannoo 13 Kansara Harkaa (Karsinomaa Seli Renal) f Columbus fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • fi 8 dabalataa
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Namoota walitti qabaa jiraSadarkaa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • fi 11 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT03866382

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

Namoota walitti qabaa jiraSadarkaa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT04981509

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Namoota walitti qabaa jiraQorannoo ilaalaa
  • The Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04981119

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

Namoota walitti qabaa jiraSadarkaa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06863311

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Namoota walitti qabaa jiraSadarkaa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT05327686

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06661720

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 1
  • Xencor Investigative Site, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT05433142

A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • James Cancer Hospital and Solove Research Institute, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2026 · NCT03972657

KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Ohio State University, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Wax-2026 · NCT06026410

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • The Ohio State University Wexner Medical Center, Columbus
Umuriin hundi · Saalaa hunda · Haaromfame 09-Bit-2026 · NCT04792463

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Namoota walitti qabaa jiraSadarkaa 1/2
  • The Ohio State University, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT06682793

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Namoota walitti qabaa jiraSadarkaa 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2025 · NCT04510597

Qorannoo Kansara Harkaa (Karsinomaa Seli Renal) magaalota biroo keessatti

Qorannoo biroo Columbus keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.